Renal & Urology News

Renal & Urology News is a digital medical news platform and a monthly printed magazine located in New York City. It provides updates on clinical information specifically for nephrologists and urologists, highlighting insights from medical conferences and articles published in peer-reviewed journals.

National, Trade/B2B

English

Magazine

Outlet metrics

Domain Authority

Ranking

Global

#1010280

United States

#326441

Health/Health Conditions and Concerns

#918

Traffic sources

Monthly visitors

Articles

SGLT2i Use May Reduce RAASi-Related Hyperkalemia Risk in Real-World Patients

1 week ago | renalandurologynews.com | natasha persaud

Sodium glucose cotransporter 2 inhibitor (SGLT2i) use is associated with lower hyperkalemia risk among real-world patients taking renin angiotensin aldosterone system inhibitors (RAASi) to treat hypertension accompanying diabetes, chronic kidney disease (CKD), or heart failure.
Diabetic Foot Ulcer Outcomes Worse for Patients With ESKD vs CKD

1 week ago | renalandurologynews.com | Ryner Lai

Among patients with diabetic foot ulcer, those with end-stage kidney disease (ESKD) fare worse than those with earlier stages of chronic kidney disease (CKD). Study findings were presented in a poster at the National Kidney Foundation 2025 Spring Clinical Meetings in Boston, Massachusetts.
Extrarenal Lupus Flares Frequent Among Patients Receiving Renal Replacement Therapy

1 week ago | renalandurologynews.com | natasha persaud

Extrarenal lupus flares continue to occur in more than one-third of patients with end-stage kidney disease (ESKD) receiving renal replacement therapy (RRT), investigators report. Flare risk is higher for patients receiving dialysis vs a kidney transplant. Investigators performed a systematic review and meta-analysis of data from 29 observational studies published 1973-2023.
Advanced CKD Tied to Worse Outcomes After Acute Myocardial Infarction Requiring Support

1 week ago | renalandurologynews.com | Ryner Lai

Patients with advanced chronic kidney disease (ACKD) with acute myocardial infarction (AMI) requiring temporary mechanical circulatory support (MCS) or undergoing coronary artery bypass grafting (CABG) are at significant risk of poor outcomes compared with similar patients without CKD. A research team presented findings from 2 related studies at the National Kidney Foundation 2025 Spring Clinical Meetings in Boston, Massachusetts.
TLD-1433 Photodynamic Therapy Shows Promise for BCG-Unresponsive NMIBC CIS

1 week ago | renalandurologynews.com | John Schieszer

Light-activated TLD-1433 photodynamic therapy (PDT) may be a viable treatment option for select patients with BCG-unresponsive non-muscle-invasive bladder cancer (NMIBC) carcinoma in situ (CIS; with or without papillary disease). An investigator presented “encouraging” interim results from a phase 2 clinical trial of the light-activated small molecule at the American Urological Association annual meeting in Las Vegas, Nevada.
Biomarker May Predict Renal Flares in Lupus Nephritis

2 weeks ago | renalandurologynews.com | natasha persaud

Immunological tests can differentiate proliferative from non-proliferative lupus nephritis, but anti-C1q antibodies and urinary erythrocytes have the best predictive power to distinguish disease class and identify kidney flare risk, investigators report. In a study, 61 patients underwent immunological tests and kidney biopsy on the same day.
Patient-Prioritized Outcomes Better After Radical Cystectomy vs Bladder Sparing Tx for NMIBC

2 weeks ago | renalandurologynews.com | John Schieszer

The CISTO study assessed patient-important outcomes after radical cystectomy (RC) and bladder-sparing therapy (BST), both standard of care treatment options for recurrent high-grade non-muscle invasive bladder cancer (NMIBC). Surprisingly, patient-prioritized outcomes were similar or better among patients choosing RC rather than BST, an investigator reported at a late-breaking session at the American Urological Association 2025 meeting in Las Vegas, Nevada.
Holmium:YAG vs Thulium Fiber Laser Similarly Effective for Kidney Stone Management

2 weeks ago | renalandurologynews.com | John Schieszer

A randomized trial found a similar stone-free rate after pulse-modulated Holmium:YAG (Ho:YAG) laser vs thulium fiber laser (TFL) treatment of kidney stones. An investigator reported trial data during a late-breaking study session at the American Urological Association annual meeting in Las Vegas, Nevada. The trial findings suggest surgeon and institutional preferences may be the best approach when selecting which laser to use, according to Margaret A.
New Robotic-Assisted Surgery System Shows Promise for Radical Genitourinary Cancer Surgeries

2 weeks ago | renalandurologynews.com | John Schieszer

The Hugo™ robotic-assisted surgery (RAS) system is safe and effective, according to late-breaking data presented at the American Urological Association 2025 meeting in Las Vegas, Nevada. The Hugo™ RAS system, currently used in more than 25 countries, is being investigated for use in the United States. The Expand URO study is a prospective, multi-center, single arm study of patients undergoing radical prostatectomy, partial or radical nephrectomy, or radical cystectomy.
Stent Omission May Be Acceptable After Ureteroscopy

2 weeks ago | renalandurologynews.com | John Schieszer

Stent omission after ureteroscopy, even with the use of a ureteral access sheath, may be superior to ureteral stent placement, according to new trial data presented at the American Urological Association annual meeting in Las Vegas, Nevada. The trial demonstrated that stent omission after ureteroscopy is safe and has better patient-reported outcomes. Current AUA guidelines state that in select patients stents can be omitted.